Kynurenic acid in brain and cerebrospinal fluid of fetal, newborn, and adult sheep and effects of placental embolization.
Concentrations of the endogenous glutamate receptor antagonist kynurenic acid (KA) were measured in various brain regions and in cisternal cerebrospinal fluid of fetal, newborn, and adult sheep. KA concentrations were significantly higher in the fetal brain and cerebrospinal fluid at 90 and 140 d gestation compared with postnatal ages. In fetuses of 132-139 d gestation, KA concentrations in cerebrospinal fluid collected by drainage from an indwelling cisternal catheter increased significantly after infusion of the organic acid transport inhibitor probenecid (100 or 200 mg/kg, i.v.) indicating active transport of KA out of the fetal brain. In fetuses in which the umbilical circulation had been chronically restricted from 120 to 140 d gestation by partial embolization of the placenta, plasma concentrations of the KA precursor kynurenine were significantly lower than in control fetuses, and KA concentrations in the hypothalamus and hippocampus were significantly reduced; other brain regions were not affected. These results indicate that the production of KA is higher in the fetal brain compared with the newborn and adult brain. Because KA diminishes the risk of excitotoxic neuronal damage under hypoxic-ischemic conditions, the high levels of KA in the brain before birth may have a neuroprotective function. The decrease of KA concentrations in the hypothalamus and hippocampus after umbilical embolization suggests that, after chronic hypoxia in utero, these regions of the brain may become more vulnerable to subsequent episodes of acute hypoxia or ischemia encountered in late gestation or during parturition.
Walker
D W
DW
Department of Physiology, Monash University, Clayton, Melbourne, Australia.
Curtis
B
B
Lacey
B
B
Nitsos
I
I
D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*; D001930:Brain Injuries / Q000196:embryology / Q000209:etiology / Q000378:metabolism; D004617:Embolism / Q000134:cerebrospinal fluid / Q000378:metabolism; D005260:Female; D005311:Fetal Hypoxia / Q000134:cerebrospinal fluid / Q000378:metabolism; D005333:Fetus / Q000378:metabolism*; D007736:Kynurenic Acid / Q000134:cerebrospinal fluid* / Q000378:metabolism*; D021041:Placental Circulation; D011247:Pregnancy; D011339:Probenecid / Q000494:pharmacology; D012756:Sheep
D007736:Kynurenic Acid; D011339:Probenecid